Doug Schenkel

Analyst

UBS

Equibles does not estimate personal net worth.

About Doug Schenkel

Doug Schenkel is recorded as Analyst at UBS. Doug Schenkel has spoken on 2 earnings calls across 2 companies, most recently for Repligen Corp on October 27, 2026. Those appearances were for Repligen Corp (RGEN) and Thermo Fisher Scientific Inc. (TMO). The companies whose calls Doug Schenkel spoke on are classified in the Healthcare sector.

Doug Schenkel on recent calls

“I want to ask a couple of questions on a quick news to laugh despite improving order trends and a growing backlog. Olivia or Jason, can you describe what's driving that disconnect?”

Analyst — UBS, Repligen to Report Third Quarter 2026 Financial Results · October 27, 2026

“Mark, many of the leading indicators appear to be moving in the right direction, clearly, pointing to an acceleration in market growth over the coming quarters.”

Analyst — UBS, Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026 · October 21, 2026